GCG and polycystic ovary syndrome: In a recent systematic review and meta-analysis, GLP1 agonists, alone or combined with metformin, appear to be more beneficial than metformin alone in reducing BMI, waist circumference, and insulin resistance in overweight and obese women with PCOS [18,19].